Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.abbvie.com
Press Release Feed
Get the latest updates from Press Release Feed directly as they happen.
Follow now 99 followers
Latest posts
Last updated over 1 year ago
AbbVie Releases New Data Demonstrating Breadth of Its Gastroenterology Portfolio at 2023 Digestive Disease Week®
about 2 years ago
- Oral presentations highlight efficacy and safety outcomes from the upadacitinib (RINVOQ®)...
AbbVie to Present at the Bank of America Securities Healthcare Conference
about 2 years ago
NORTH CHICAGO, Ill., May 2, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will...
AbbVie Reports First-Quarter 2023 Financial Results
about 2 years ago
NORTH CHICAGO, Ill., April 27, 2023 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial...
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant (QULIPTA®) for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting
about 2 years ago
NORTH CHICAGO, Ill., April 21, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today...
Allergan Aesthetics Celebrates the Journeys of Women Surgeons with LIMITLESS
about 2 years ago
IRVINE, Calif., April 18, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company...
U.S. FDA Approves QULIPTA® (atogepant) for Adults With Chronic Migraine
about 2 years ago
NORTH CHICAGO, Ill., April 17, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) today...
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Moderately to Severely Active Crohn's Disease
about 2 years ago
– Seventh approved indication for RINVOQ in the European Union (EU) and...
AbbVie Invites College Students Living with Cystic Fibrosis to Apply for the AbbVie CF Scholarship for the 2023-2024 Academic School Year
about 2 years ago
NORTH CHICAGO, Ill., April 12, 2023 /PRNewswire/ -- AbbVie today announced that...
Update on IMBRUVICA® (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications
about 2 years ago
NORTH CHICAGO, Ill., XX – AbbVie (NYSE: ABBV) announced today the intent...
AbbVie to Host First-Quarter 2023 Earnings Conference Call
about 2 years ago
NORTH CHICAGO, Ill., April 4, 2023 /PRNewswire/ -- AbbVie (NYSE: ABBV) will...
CoolSculpting® Elite Announces First Ever CoolMonth
about 2 years ago
IRVINE, Calif., April 3, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company...
Allergan Aesthetics* to showcase 360° approach to clinical practice, aesthetic products, and patients with expert-led symposia at AMWC 2023
about 2 years ago
IRVINE, Calif., March 29, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie (NYSE...